| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.678 | 0.008 | 0.678 | Vasodilator, peripheral | 0.672 0.008 CID_21186619 | ||
| 0.66 | 0.005 | 0.676 | Psychostimulant | 0.676 0.005 CID_21186619 | CID_21186619 | |
| 0.569 | 0.018 | 0.601 | 5 Hydroxytryptamine release stimulant | 0.601 0.014 CID_21186619 | CID_21186619 | |
| 0.506 | 0.012 | 0.531 | Vasodilator | 0.531 0.01 CID_21186619 | CID_21186619 | |
| 0.41 | 0.021 | 0.41 | Calcium channel activator | 0.359 0.044 CID_21186619 | ||
| 0.388 | 0.003 | 0.392 | Dopamine transporter inhibitor | 0.392 0.003 CID_21186619 | CID_21186619 | |
| 0.382 | 0.004 | 0.387 | Adrenaline uptake inhibitor | 0.387 0.004 CID_21186619 | CID_21186619 | |
| 0.382 | 0.005 | 0.382 | 5 Hydroxytryptamine uptake inhibitor | 0.338 0.005 CID_21186619 | ||
| 0.377 | 0.013 | 0.378 | DNA methylase inhibitor | 0.378 0.013 CID_21186619 | CID_21186619 | |
| 0.368 | 0.021 | 0.398 | 5 Hydroxytryptamine uptake stimulant | 0.398 0.015 CID_21186619 | CID_21186619 | |
| 0.366 | 0.033 | 0.408 | Superoxide dismutase inhibitor | 0.408 0.025 CID_21186619 | CID_21186619 | |
| 0.342 | 0.025 | 0.396 | Anesthetic general | 0.396 0.017 CID_21186619 | CID_21186619 | |
| 0.349 | 0.056 | 0.349 | Vasodilator, coronary | 0.317 0.075 CID_21186619 | ||
| 0.318 | 0.025 | 0.451 | Tyrosine 3 hydroxylase inhibitor | 0.451 0.005 CID_21186619 | CID_21186619 | |
| 0.304 | 0.025 | 0.307 | DNA methyltransferase I inhibitor | 0.307 0.024 CID_21186619 | CID_21186619 | |
| 0.28 | 0.004 | 0.28 | Nicotinic alpha4beta2 receptor antagonist | 0.246 0.004 CID_21186619 | ||
| 0.39 | 0.117 | 0.39 | Caspase 9 stimulant | 0.359 0.138 CID_21186619 | ||
| 0.328 | 0.06 | 0.367 | Spasmolytic | 0.367 0.048 CID_21186619 | CID_21186619 | |
| 0.262 | 0.002 | 0.262 | Nicotinic alpha3beta2 receptor antagonist | 0.254 0.002 CID_21186619 | ||
| 0.263 | 0.008 | 0.263 | Acetylcholine nicotinic antagonist | 0.246 0.009 CID_21186619 | ||
| 0.358 | 0.109 | 0.391 | 5 Hydroxytryptamine release inhibitor | 0.391 0.084 CID_21186619 | CID_21186619 | |
| 0.258 | 0.018 | 0.258 | Anesthetic local | 0.243 0.021 CID_21186619 | ||
| 0.364 | 0.129 | 0.426 | Alpha-glucosidase inhibitor | 0.426 0.104 CID_21186619 | CID_21186619 | |
| 0.239 | 0.004 | 0.249 | Nicotinic receptor alpha3 subunit antagonist | 0.249 0.004 CID_21186619 | CID_21186619 | |
| 0.315 | 0.082 | 0.378 | Cholesterol antagonist | 0.378 0.055 CID_21186619 | CID_21186619 | |
| 0.24 | 0.009 | 0.24 | MAP kinase kinase 5 inhibitor | 0.22 0.017 CID_21186619 | ||
| 0.237 | 0.007 | 0.237 | Neuronal nicotinic receptor antagonist | 0.214 0.008 CID_21186619 | ||
| 0.253 | 0.03 | 0.253 | Tumour necrosis factor antagonist | 0.148 0.103 CID_21186619 | ||
| 0.236 | 0.024 | 0.284 | Cholinergic antagonist | 0.284 0.016 CID_21186619 | CID_21186619 | |
| 0.322 | 0.115 | 0.322 | MAP kinase kinase 6 inhibitor | 0.316 0.12 CID_21186619 | ||
| 0.229 | 0.024 | 0.274 | Acetylcholine antagonist | 0.274 0.017 CID_21186619 | CID_21186619 | |
| 0.222 | 0.027 | 0.222 | Toll-Like receptor 9 antagonist | 0.159 0.057 CID_21186619 | ||
| 0.197 | 0.004 | 0.202 | Nicotinic receptor alpha4 subunit antagonist | 0.202 0.004 CID_21186619 | CID_21186619 | |
| 0.193 | 0.007 | 0.193 | Dopamine uptake inhibitor | 0.177 0.008 CID_21186619 | ||
| 0.343 | 0.159 | 0.343 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.338 0.165 CID_21186619 | ||
| 0.324 | 0.153 | 0.324 | DNA polymerase beta inhibitor | 0.279 0.176 CID_21186619 | ||
| 0.174 | 0.003 | 0.191 | Nicotinic receptor beta4 subunit antagonist | 0.191 0.003 CID_21186619 | CID_21186619 | |
| 0.251 | 0.082 | 0.456 | Aldehyde oxidase inhibitor | 0.456 0.039 CID_21186619 | CID_21186619 | |
| 0.3 | 0.134 | 0.3 | Beta lactamase inhibitor | |||
| 0.192 | 0.029 | 0.192 | Alpha adrenoreceptor antagonist | 0.104 0.054 CID_21186619 | ||
| 0.183 | 0.023 | 0.183 | Falcipain 3 inhibitor | 0.166 0.03 CID_21186619 | ||
| 0.178 | 0.029 | 0.178 | Nav1.6 sodium channel blocker | 0.151 0.053 CID_21186619 | ||
| 0.222 | 0.079 | 0.222 | Cyclic AMP phosphodiesterase inhibitor | 0.222 0.079 CID_21186619 | ||
| 0.188 | 0.045 | 0.188 | MAO inhibitor | 0.188 0.044 CID_21186619 | ||
| 0.232 | 0.094 | 0.232 | 5 Hydroxytryptamine 1E antagonist | 0.213 0.116 CID_21186619 | ||
| 0.185 | 0.05 | 0.251 | Amylase inhibitor | 0.251 0.028 CID_21186619 | CID_21186619 | |
| 0.157 | 0.022 | 0.157 | Sphingomyelinase inhibitor | 0.11 0.049 CID_21186619 | ||
| 0.197 | 0.068 | 0.197 | 5 Hydroxytryptamine 3E antagonist | 0.187 0.087 CID_21186619 | ||
| 0.132 | 0.01 | 0.132 | Granulocyte macrophage colony stimulating factor agonist | 0.107 0.026 CID_21186619 | ||
| 0.288 | 0.168 | 0.414 | Calcium channel L-type activator | 0.414 0.072 CID_21186619 | CID_21186619 | |
| 0.16 | 0.042 | 0.16 | Nav1.3 sodium channel blocker | 0.125 0.068 CID_21186619 | ||
| 0.197 | 0.079 | 0.274 | Neurotrophic factor enhancer | 0.274 0.027 CID_21186619 | CID_21186619 | |
| 0.14 | 0.026 | 0.14 | Calcium antagonist | |||
| 0.146 | 0.035 | 0.167 | Nav1.1 sodium channel blocker | 0.167 0.027 CID_21186619 | CID_21186619 | |
| 0.137 | 0.027 | 0.137 | Acetylcholine release stimulant | 0.1 0.087 CID_21186619 | ||
| 0.167 | 0.067 | 0.191 | Neurotensin receptor agonist | 0.191 0.04 CID_21186619 | CID_21186619 | |
| 0.17 | 0.073 | 0.17 | Sigma receptor agonist | 0.144 0.09 CID_21186619 | ||
| 0.144 | 0.058 | 0.161 | Ca2+-transporting ATPase inhibitor | 0.161 0.023 CID_21186619 | CID_21186619 | |
| 0.104 | 0.018 | 0.148 | CC chemokine 5 receptor agonist | 0.148 0.004 CID_21186619 | CID_21186619 | |
| 0.117 | 0.033 | 0.117 | Glutamate (mGluR7) agonist | |||
| 0.245 | 0.161 | 0.277 | Antiobesity | 0.277 0.133 CID_21186619 | CID_21186619 | |
| 0.156 | 0.074 | 0.178 | Melanin inhibitor | 0.178 0.053 CID_21186619 | CID_21186619 | |
| 0.264 | 0.183 | 0.264 | DNA directed DNA polymerase inhibitor | 0.247 0.194 CID_21186619 | ||
| 0.1 | 0.02 | 0.1 | Acetylcholine M5 receptor agonist | |||
| 0.188 | 0.111 | 0.206 | Nitric-oxide synthase stimulant | 0.206 0.08 CID_21186619 | CID_21186619 | |
| 0.129 | 0.052 | 0.129 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.198 | 0.122 | 0.231 | Neuropeptide Y2 antagonist | 0.231 0.076 CID_21186619 | CID_21186619 | |
| 0.164 | 0.089 | 0.188 | Succinate dehydrogenase inhibitor | 0.188 0.06 CID_21186619 | CID_21186619 | |
| 0.222 | 0.151 | 0.273 | Antithrombotic | 0.273 0.109 CID_21186619 | CID_21186619 | |
| 0.099 | 0.029 | 0.114 | Interferon agonist | 0.114 0.02 CID_21186619 | CID_21186619 | |
| 0.08 | 0.013 | 0.08 | 5 Hydroxytryptamine 4 antagonist | 0.055 0.029 CID_21186619 | ||
| 0.083 | 0.016 | 0.083 | Nicotinic receptor alpha7 subunit antagonist | 0.072 0.02 CID_21186619 | ||
| 0.1 | 0.033 | 0.1 | mTOR complex 2 inhibitor | 0.098 0.035 CID_21186619 | ||
| 0.13 | 0.066 | 0.132 | Vanilloid 1 agonist | 0.132 0.062 CID_21186619 | CID_21186619 | |
| 0.111 | 0.047 | 0.111 | Antihistaminic | 0.083 0.074 CID_21186619 | ||
| 0.142 | 0.078 | 0.142 | Neuropeptide Y1 antagonist | 0.14 0.081 CID_21186619 | ||
| 0.125 | 0.062 | 0.125 | DNA repair enzyme inhibitor | 0.124 0.065 CID_21186619 | ||
| 0.087 | 0.025 | 0.11 | Phospholipase D inhibitor | 0.11 0.01 CID_21186619 | CID_21186619 | |
| 0.129 | 0.068 | 0.129 | Antibacterial (Helicobacter pylori) | 0.126 0.073 CID_21186619 | ||
| 0.068 | 0.007 | 0.087 | GABA uptake inhibitor | 0.087 0.004 CID_21186619 | CID_21186619 | |
| 0.129 | 0.069 | 0.257 | Alpha-N-acetylglucosaminidase inhibitor | 0.257 0.022 CID_21186619 | CID_21186619 | |
| 0.076 | 0.019 | 0.076 | Calcium channel P-type blocker | |||
| 0.07 | 0.014 | 0.081 | Squalene epoxidase inhibitor | 0.081 0.009 CID_21186619 | CID_21186619 | |
| 0.093 | 0.038 | 0.093 | Alpha 1b adrenoreceptor antagonist | |||
| 0.15 | 0.095 | 0.157 | Cyclin-dependent kinase 3 inhibitor | 0.157 0.082 CID_21186619 | CID_21186619 | |
| 0.071 | 0.016 | 0.071 | Ryanodine receptor antagonist | 0.057 0.048 CID_21186619 | ||
| 0.101 | 0.047 | 0.101 | Histamine antagonist | |||
| 0.089 | 0.035 | 0.089 | Viral attachment inhibitor | 0.088 0.036 CID_21186619 | ||
| 0.103 | 0.052 | 0.13 | Lanosterol 14 alpha demethylase inhibitor | 0.13 0.022 CID_21186619 | CID_21186619 | |
| 0.081 | 0.031 | 0.081 | Potassium channel (Tandem pore domain) blocker | 0.07 0.065 CID_21186619 | ||
| 0.068 | 0.02 | 0.075 | CC chemokine 5 receptor antagonist | 0.075 0.015 CID_21186619 | CID_21186619 | |
| 0.125 | 0.077 | 0.125 | Toll-Like receptor antagonist | 0.118 0.088 CID_21186619 | ||
| 0.065 | 0.02 | 0.065 | Histamine H3 receptor antagonist | |||
| 0.078 | 0.033 | 0.078 | Dopamine D3 antagonist | 0.057 0.048 CID_21186619 | ||
| 0.1 | 0.056 | 0.167 | Prolactin inhibitor | 0.167 0.016 CID_21186619 | CID_21186619 | |
| 0.061 | 0.017 | 0.061 | CC chemokine receptor 2B antagonist | 0.059 0.019 CID_21186619 | ||
| 0.154 | 0.111 | 0.154 | P-glycoprotein inhibitor | |||
| 0.14 | 0.098 | 0.206 | Heat shock protein 90 alpha antagonist | 0.206 0.046 CID_21186619 | CID_21186619 | |
| 0.051 | 0.012 | 0.052 | Heme oxygenase inhibitor | 0.052 0.011 CID_21186619 | CID_21186619 | |
| 0.128 | 0.088 | 0.128 | Death-associated protein kinase 1 inhibitor | |||
| 0.084 | 0.045 | 0.084 | Dopamine antagonist | 0.067 0.056 CID_21186619 | ||
| 0.107 | 0.068 | 0.107 | Electron transport complex I inhibitor | |||
| 0.113 | 0.074 | 0.15 | Transcription factor STAT6 inhibitor | 0.15 0.023 CID_21186619 | CID_21186619 | |
| 0.125 | 0.087 | 0.14 | Neurotrophic factor | 0.14 0.069 CID_21186619 | CID_21186619 | |
| 0.139 | 0.102 | 0.171 | Arachidonic acid antagonist | 0.171 0.065 CID_21186619 | CID_21186619 | |
| 0.086 | 0.052 | 0.086 | Histamine H1 receptor antagonist | 0.075 0.063 CID_21186619 | ||
| 0.094 | 0.06 | 0.094 | Antiadrenergic | |||
| 0.109 | 0.076 | 0.109 | Microtubule formation inhibitor | 0.104 0.083 CID_21186619 | ||
| 0.045 | 0.012 | 0.045 | Histamine H3 receptor agonist | 0.029 0.018 CID_21186619 | ||
| 0.046 | 0.015 | 0.047 | Delayed rectifier potassium channel blocker | 0.047 0.014 CID_21186619 | CID_21186619 | |
| 0.06 | 0.029 | 0.061 | Myc inhibitor | 0.061 0.028 CID_21186619 | CID_21186619 | |
| 0.09 | 0.06 | 0.09 | Adrenaline antagonist | |||
| 0.041 | 0.011 | 0.041 | Adenosine uptake inhibitor | 0.035 0.022 CID_21186619 | ||
| 0.064 | 0.034 | 0.064 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.191 | 0.162 | 0.194 | Gastrin inhibitor | 0.194 0.157 CID_21186619 | CID_21186619 | |
| 0.086 | 0.058 | 0.264 | NMDA receptor antagonist | 0.264 0.008 CID_21186619 | CID_21186619 | |
| 0.084 | 0.055 | 0.104 | Estrogen-related receptor beta agonist | 0.104 0.02 CID_21186619 | CID_21186619 | |
| 0.153 | 0.126 | 0.153 | Focal adhesion kinase 2 inhibitor | |||
| 0.115 | 0.089 | 0.115 | Nav1.2 sodium channel blocker | |||
| 0.091 | 0.065 | 0.104 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.104 0.05 CID_21186619 | CID_21186619 | |
| 0.064 | 0.038 | 0.064 | Alpha 1d adrenoreceptor antagonist | |||
| 0.035 | 0.009 | 0.052 | Estrogen-related receptor gamma antagonist | 0.052 0.003 CID_21186619 | CID_21186619 | |
| 0.038 | 0.013 | 0.038 | Sigma 2 receptor antagonist | 0.034 0.015 CID_21186619 | ||
| 0.031 | 0.006 | 0.031 | 5 Hydroxytryptamine 4 agonist | 0.024 0.019 CID_21186619 | ||
| 0.082 | 0.057 | 0.082 | Caspase 7 inhibitor | |||
| 0.116 | 0.092 | 0.148 | Papain-like protease (SARS coronavirus) inhibitor | 0.148 0.035 CID_21186619 | CID_21186619 | |
| 0.052 | 0.027 | 0.052 | Cholesterol esterase inhibitor | 0.048 0.032 CID_21186619 | ||
| 0.077 | 0.054 | 0.13 | Estrogen receptor alpha antagonist | 0.13 0.016 CID_21186619 | CID_21186619 | |
| 0.062 | 0.04 | 0.069 | TRPA1 antagonist | 0.069 0.033 CID_21186619 | CID_21186619 | |
| 0.05 | 0.028 | 0.05 | Benzodiazepine antagonist | |||
| 0.046 | 0.024 | 0.076 | CDK5/p25 inhibitor | 0.076 0.01 CID_21186619 | CID_21186619 | |
| 0.046 | 0.025 | 0.046 | Guanylate cyclase inhibitor | 0.045 0.027 CID_21186619 | ||
| 0.131 | 0.109 | 0.156 | Interferon gamma antagonist | 0.156 0.071 CID_21186619 | CID_21186619 | |
| 0.099 | 0.079 | 0.103 | Mucolytic | 0.103 0.073 CID_21186619 | CID_21186619 | |
| 0.041 | 0.02 | 0.041 | Vanilloid 3 antagonist | |||
| 0.091 | 0.071 | 0.106 | Bile acid receptor antagonist | 0.106 0.038 CID_21186619 | CID_21186619 | |
| 0.169 | 0.15 | 0.219 | Interleukin agonist | 0.219 0.103 CID_21186619 | CID_21186619 | |
| 0.035 | 0.017 | 0.063 | Estrogen-related receptor beta antagonist | 0.063 0.004 CID_21186619 | CID_21186619 | |
| 0.095 | 0.079 | 0.106 | Toll-Like receptor 4 antagonist | 0.106 0.06 CID_21186619 | CID_21186619 | |
| 0.108 | 0.092 | 0.148 | Toll-Like receptor 2 antagonist | 0.148 0.054 CID_21186619 | CID_21186619 | |
| 0.096 | 0.081 | 0.129 | 5 Hydroxytryptamine 3A agonist | 0.129 0.049 CID_21186619 | CID_21186619 | |
| 0.208 | 0.193 | 0.311 | Histamine release inhibitor | 0.311 0.118 CID_21186619 | CID_21186619 | |
| 0.088 | 0.073 | 0.096 | MAO A inhibitor | 0.096 0.067 CID_21186619 | CID_21186619 | |
| 0.055 | 0.041 | 0.055 | 5 Hydroxytryptamine 7 agonist | |||
| 0.107 | 0.093 | 0.107 | Acetylcholinesterase inhibitor | |||
| 0.052 | 0.038 | 0.052 | Alpha 1L adrenoreceptor antagonist | |||
| 0.052 | 0.038 | 0.052 | Histamine agonist | |||
| 0.067 | 0.056 | 0.067 | Calcium channel L-type blocker | |||
| 0.034 | 0.023 | 0.034 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.087 | 0.076 | 0.244 | Creatine kinase inhibitor | 0.244 0.006 CID_21186619 | CID_21186619 | |
| 0.137 | 0.126 | 0.137 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.034 | 0.023 | 0.034 | Carnitine palmitoyltransferase inhibitor | |||
| 0.064 | 0.054 | 0.064 | Alpha 1a adrenoreceptor antagonist | |||
| 0.036 | 0.027 | 0.041 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.041 0.02 CID_21186619 | CID_21186619 | |
| 0.102 | 0.092 | 0.102 | Calcium channel N-type blocker | |||
| 0.084 | 0.074 | 0.084 | Breast cancer-resistant protein inhibitor | |||
| 0.069 | 0.06 | 0.069 | Alpha 1 adrenoreceptor antagonist | |||
| 0.084 | 0.076 | 0.084 | Glutamate release inhibitor | |||
| 0.045 | 0.037 | 0.045 | CC chemokine 4 receptor antagonist | |||
| 0.067 | 0.06 | 0.08 | Glycine receptor agonist | 0.08 0.038 CID_21186619 | CID_21186619 | |
| 0.069 | 0.063 | 0.111 | GABA aminotransferase inhibitor | 0.111 0.02 CID_21186619 | CID_21186619 | |
| 0.047 | 0.041 | 0.052 | Prolyl endopeptidase inhibitor | 0.052 0.033 CID_21186619 | CID_21186619 | |
| 0.042 | 0.037 | 0.066 | Glycine transporter 2 inhibitor | 0.066 0.022 CID_21186619 | CID_21186619 | |
| 0.094 | 0.089 | 0.094 | Interleukin 1b antagonist | |||
| 0.08 | 0.076 | 0.08 | Phosphodiesterase I inhibitor | |||
| 0.097 | 0.094 | 0.124 | Acetylcholine muscarinic antagonist | 0.124 0.063 CID_21186619 | CID_21186619 | |
| 0.198 | 0.195 | 0.198 | Ca(v)3.3 blocker | |||
| 0.084 | 0.082 | 0.157 | UDP-glucose 4-epimerase inhibitor | 0.157 0.027 CID_21186619 | CID_21186619 | |
| 0.086 | 0.084 | 0.086 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.055 | 0.054 | 0.055 | Phosphodiesterase 1A inhibitor | |||
| 0.024 | 0.022 | 0.024 | Acid ceramidase inhibitor | |||
| 0.014 | 0.013 | 0.018 | NMDA receptor phencyclidine site antagonist | 0.018 0.009 CID_21186619 | CID_21186619 | |
| 0.134 | 0.133 | 0.146 | ATPase inhibitor | 0.146 0.108 CID_21186619 | CID_21186619 | |
| 0.153 | 0.153 | 0.263 | Immunostimulant | 0.263 0.091 CID_21186619 | CID_21186619 | |
| 0.04 | 0.04 | 0.042 | Glutamate (mGluR group III) antagonist | 0.042 0.035 CID_21186619 | CID_21186619 | |
| 0.094 | 0.095 | 0.116 | Cholesterol synthesis inhibitor | 0.116 0.069 CID_21186619 | CID_21186619 | |
| 0.074 | 0.075 | 0.114 | Histamine N-methyltransferase inhibitor | 0.114 0.034 CID_21186619 | CID_21186619 | |
| 0.058 | 0.059 | 0.07 | Interferon inducer | 0.07 0.035 CID_21186619 | CID_21186619 | |
| 0.039 | 0.042 | 0.051 | Glutamate (mGluR4) antagonist | 0.051 0.02 CID_21186619 | CID_21186619 | |
| 0.017 | 0.02 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.015 CID_21186619 | CID_21186619 | |
| 0.056 | 0.061 | 0.059 | Protease 3C (Human rhinovirus) inhibitor | 0.059 0.054 CID_21186619 | CID_21186619 | |
| 0.112 | 0.117 | 0.127 | Sphingosine 1-phosphate receptor 2 antagonist | 0.127 0.08 CID_21186619 | CID_21186619 | |
| 0.16 | 0.166 | 0.225 | MAP-kinase-activated kinase 5 inhibitor | 0.225 0.078 CID_21186619 | CID_21186619 | |
| 0.181 | 0.188 | 0.254 | Insulysin inhibitor | 0.254 0.093 CID_21186619 | CID_21186619 | |
| 0.076 | 0.084 | 0.115 | HIV-1 integrase (Overall Integration) inhibitor | 0.115 0.043 CID_21186619 | CID_21186619 | |
| 0.05 | 0.058 | 0.053 | Immunoglobulin Fc receptor antagonist | 0.053 0.047 CID_21186619 | CID_21186619 | |
| 0.094 | 0.103 | 0.105 | Caspase 3 inhibitor | 0.105 0.083 CID_21186619 | CID_21186619 | |
| 0.03 | 0.039 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.02 CID_21186619 | CID_21186619 | |
| 0.104 | 0.114 | 0.129 | Protein kinase stimulant | 0.129 0.084 CID_21186619 | CID_21186619 | |
| 0.114 | 0.125 | 0.162 | Heat shock protein 90 antagonist | 0.162 0.063 CID_21186619 | CID_21186619 | |
| 0.118 | 0.13 | 0.139 | Sphingosine 1-phosphate receptor 5 antagonist | 0.139 0.082 CID_21186619 | CID_21186619 | |
| 0.059 | 0.071 | 0.146 | Glutamate decarboxylase inhibitor | 0.146 0.014 CID_21186619 | CID_21186619 | |
| 0.015 | 0.026 | 0.027 | Estrogen-related receptor gamma agonist | 0.027 0.005 CID_21186619 | CID_21186619 | |
| 0.098 | 0.11 | 0.102 | Sphingosine 1-phosphate receptor 2 agonist | 0.102 0.097 CID_21186619 | CID_21186619 | |
| 0.07 | 0.083 | 0.102 | MAP kinase kinase 7 inhibitor | 0.102 0.011 CID_21186619 | CID_21186619 | |
| 0.091 | 0.106 | 0.109 | TRPA1 agonist | 0.109 0.074 CID_21186619 | CID_21186619 | |
| 0.05 | 0.065 | 0.071 | Dopamine D1 antagonist | 0.071 0.039 CID_21186619 | CID_21186619 | |
| 0.035 | 0.05 | 0.04 | Kainate receptor agonist | 0.04 0.032 CID_21186619 | CID_21186619 | |
| 0.197 | 0.212 | 0.369 | GABA C receptor rho-3 antagonist | 0.369 0.076 CID_21186619 | CID_21186619 | |
| 0.092 | 0.108 | 0.168 | Glutamate receptor antagonist | 0.168 0.04 CID_21186619 | CID_21186619 | |
| 0.057 | 0.074 | 0.069 | Cathepsin G inhibitor | 0.069 0.055 CID_21186619 | CID_21186619 | |
| 0.066 | 0.084 | 0.08 | GABA B receptor agonist | 0.08 0.043 CID_21186619 | CID_21186619 | |
| 0.098 | 0.116 | 0.108 | NADPH oxidase inhibitor | 0.108 0.099 CID_21186619 | CID_21186619 | |
| 0.108 | 0.126 | 0.142 | Acetylcholine M1 receptor antagonist | 0.142 0.082 CID_21186619 | CID_21186619 | |
| 0.045 | 0.065 | 0.059 | Cyclin-dependent kinase 6 inhibitor | 0.059 0.043 CID_21186619 | CID_21186619 | |
| 0.109 | 0.131 | 0.152 | Farnesoid X receptor antagonist | 0.152 0.05 CID_21186619 | CID_21186619 | |
| 0.082 | 0.103 | 0.138 | Cystathionine beta-synthase inhibitor | 0.138 0.046 CID_21186619 | CID_21186619 | |
| 0.086 | 0.111 | 0.144 | DOPA decarboxylase inhibitor | 0.144 0.025 CID_21186619 | CID_21186619 | |
| 0.051 | 0.078 | 0.076 | Catalase inhibitor | 0.076 0.05 CID_21186619 | CID_21186619 | |
| 0.042 | 0.07 | 0.062 | Sphingosine kinase 2 inhibitor | 0.062 0.029 CID_21186619 | CID_21186619 | |
| 0.021 | 0.05 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.032 0.023 CID_21186619 | CID_21186619 | |
| 0.039 | 0.072 | 0.052 | Alpha-mannosidase inhibitor | 0.052 0.039 CID_21186619 | CID_21186619 | |
| 0.052 | 0.085 | 0.1 | Aminopeptidase I inhibitor | 0.1 0.028 CID_21186619 | CID_21186619 | |
| 0.026 | 0.06 | 0.077 | Dopamine D5 agonist | 0.077 0.007 CID_21186619 | CID_21186619 | |
| 0.112 | 0.146 | 0.126 | GABA C receptor rho-2 antagonist | 0.126 0.114 CID_21186619 | CID_21186619 | |
| 0.042 | 0.077 | 0.087 | NMDA 2C receptor antagonist | 0.087 0.021 CID_21186619 | CID_21186619 | |
| 0.139 | 0.182 | 0.159 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.159 0.129 CID_21186619 | CID_21186619 | |
| 0.034 | 0.079 | 0.068 | Argininosuccinate synthase inhibitor | 0.068 0.031 CID_21186619 | CID_21186619 | |
| 0.049 | 0.095 | 0.061 | Heme oxygenase stimulant | 0.061 0.043 CID_21186619 | CID_21186619 | |
| 0.109 | 0.155 | 0.15 | Adenylate cyclase stimulant | 0.15 0.062 CID_21186619 | CID_21186619 | |
| 0.022 | 0.071 | 0.054 | Oxytocin agonist | 0.054 0.021 CID_21186619 | CID_21186619 | |
| 0.069 | 0.119 | 0.147 | GABA C receptor agonist | 0.147 0.035 CID_21186619 | CID_21186619 | |
| 0.085 | 0.136 | 0.171 | Estrogen antagonist | 0.171 0.017 CID_21186619 | CID_21186619 | |
| 0.067 | 0.12 | 0.085 | D-Ala-D-Ala ligase inhibitor | 0.085 0.056 CID_21186619 | CID_21186619 | |
| 0.103 | 0.158 | 0.126 | Hemostatic | 0.126 0.103 CID_21186619 | CID_21186619 | |
| 0.07 | 0.124 | 0.154 | Estrogen receptor beta antagonist | 0.154 0.015 CID_21186619 | CID_21186619 | |
| 0.065 | 0.12 | 0.088 | NADH dehydrogenase inhibitor | 0.088 0.06 CID_21186619 | CID_21186619 | |
| 0.069 | 0.13 | 0.095 | GABA C receptor rho-1 antagonist | 0.095 0.07 CID_21186619 | CID_21186619 | |
| 0.105 | 0.166 | 0.132 | Nitric oxide antagonist | 0.132 0.116 CID_21186619 | CID_21186619 | |
| 0.067 | 0.129 | 0.089 | Protein kinase C zeta inhibitor | 0.089 0.067 CID_21186619 | CID_21186619 | |
| 0.017 | 0.083 | 0.068 | NMDA receptor subunit 3A antagonist | 0.068 0.015 CID_21186619 | CID_21186619 | |
| 0.051 | 0.117 | 0.06 | Prolactin release inhibitor | 0.06 0.051 CID_21186619 | CID_21186619 | |
| 0.044 | 0.111 | 0.067 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.067 0.065 CID_21186619 | CID_21186619 | |
| 0.065 | 0.136 | 0.105 | Anabolic | 0.105 0.056 CID_21186619 | CID_21186619 | |
| 0.109 | 0.181 | 0.129 | Antipruritic | 0.129 0.124 CID_21186619 | CID_21186619 | |
| 0.028 | 0.101 | 0.09 | Alcohol oxidase inhibitor | 0.09 0.021 CID_21186619 | CID_21186619 | |
| 0.019 | 0.093 | 0.078 | NMDA 2A receptor antagonist | 0.078 0.021 CID_21186619 | CID_21186619 | |
| 0.052 | 0.128 | 0.098 | Opioid kappa receptor antagonist | 0.098 0.037 CID_21186619 | CID_21186619 | |
| 0.153 | 0.231 | 0.178 | Transcription factor STAT inhibitor | 0.178 0.172 CID_21186619 | CID_21186619 | |
| 0.03 | 0.113 | 0.063 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.063 0.027 CID_21186619 | CID_21186619 | |
| 0.058 | 0.143 | 0.092 | Triose-phosphate isomerase inhibitor | 0.092 0.057 CID_21186619 | CID_21186619 | |
| 0.036 | 0.126 | 0.057 | Sphingosine kinase inhibitor | 0.057 0.045 CID_21186619 | CID_21186619 | |
| 0.114 | 0.206 | 0.163 | Phospholipase C inhibitor | 0.163 0.082 CID_21186619 | CID_21186619 | |
| 0.158 | 0.256 | 0.211 | Apoptosis antagonist | 0.211 0.165 CID_21186619 | CID_21186619 | |
| 0.058 | 0.166 | 0.087 | Carbonic anhydrase III inhibitor | 0.087 0.079 CID_21186619 | CID_21186619 | |
| 0.076 | 0.184 | 0.231 | Peroxidase inhibitor | 0.231 0.052 CID_21186619 | CID_21186619 | |
| 0.031 | 0.145 | 0.066 | Histidine decarboxylase inhibitor | 0.066 0.055 CID_21186619 | CID_21186619 | |
| 0.06 | 0.174 | 0.111 | GABA C receptor antagonist | 0.111 0.063 CID_21186619 | CID_21186619 | |
| 0.044 | 0.16 | 0.103 | Opioid antagonist | 0.103 0.045 CID_21186619 | CID_21186619 | |
| 0.056 | 0.174 | 0.103 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.103 0.098 CID_21186619 | CID_21186619 | |
| 0.044 | 0.162 | 0.102 | Aminopeptidase B inhibitor | 0.102 0.064 CID_21186619 | CID_21186619 | |
| 0.127 | 0.248 | 0.182 | 12-Lipoxygenase inhibitor | 0.182 0.171 CID_21186619 | CID_21186619 | |
| 0.036 | 0.16 | 0.078 | Analgesic, opioid | 0.078 0.051 CID_21186619 | CID_21186619 | |
| 0.022 | 0.146 | 0.096 | NMDA 2 receptor antagonist | 0.096 0.034 CID_21186619 | CID_21186619 | |
| 0.066 | 0.194 | 0.104 | Aldehyde dehydrogenase inhibitor | 0.104 0.091 CID_21186619 | CID_21186619 | |
| 0.125 | 0.259 | 0.185 | Transcription factor NF kappa B inhibitor | 0.185 0.184 CID_21186619 | CID_21186619 | |
| 0.018 | 0.166 | 0.04 | AMPA 4 receptor antagonist | 0.04 0.027 CID_21186619 | CID_21186619 | |
| 0.009 | 0.162 | 0.057 | Estrogen agonist | 0.057 0.032 CID_21186619 | CID_21186619 | |
| 0.025 | 0.188 | 0.086 | Porphobilinogen synthase inhibitor | 0.086 0.043 CID_21186619 | CID_21186619 | |
| 0.017 | 0.182 | 0.068 | Opioid mu receptor antagonist | 0.068 0.048 CID_21186619 | CID_21186619 | |
| 0.069 | 0.239 | 0.123 | Cell wall synthesis inhibitor | 0.123 0.096 CID_21186619 | CID_21186619 | |
| 0.05 | 0.229 | 0.125 | Lipid peroxidase inhibitor | 0.125 0.089 CID_21186619 | CID_21186619 | |
| 0.004 | 0.187 | 0.032 | Estrogen receptor alpha agonist | 0.032 0.025 CID_21186619 | CID_21186619 | |
| 0.021 | 0.205 | 0.048 | NMDA 2B receptor antagonist | 0.048 0.047 CID_21186619 | CID_21186619 | |
| 0.111 | 0.299 | 0.173 | DNA synthesis inhibitor | 0.173 0.163 CID_21186619 | CID_21186619 | |
| 0.139 | 0.329 | 0.258 | Interleukin 2 agonist | 0.258 0.11 CID_21186619 | CID_21186619 | |
| 0.014 | 0.206 | 0.053 | Opioid delta receptor antagonist | 0.053 0.052 CID_21186619 | CID_21186619 | |
| 0.081 | 0.274 | 0.179 | Free radical scavenger | 0.179 0.116 CID_21186619 | CID_21186619 | |
| 0.087 | 0.283 | 0.187 | Antioxidant | 0.187 0.125 CID_21186619 | CID_21186619 | |
| 0.021 | 0.22 | 0.079 | Phenylalanine 4-hydroxylase inhibitor | 0.079 0.038 CID_21186619 | CID_21186619 | |
| 0.123 | 0.325 | 0.232 | Sodium/bile acid cotransporter inhibitor | 0.232 0.148 CID_21186619 | CID_21186619 | |
| 0.04 | 0.245 | 0.102 | Chelator | 0.102 0.075 CID_21186619 | CID_21186619 | |
| 0.129 | 0.336 | 0.233 | Antibacterial | 0.233 0.194 CID_21186619 | CID_21186619 | |
| 0.028 | 0.256 | 0.063 | HIV-1 integrase inhibitor | 0.063 0.061 CID_21186619 | CID_21186619 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |